Literature DB >> 15616168

Pathological laughing and crying following traumatic brain injury.

Amane Tateno1, Ricardo E Jorge, Robert G Robinson.   

Abstract

The authors examined the prevalence and clinical correlates of pathological laughing and crying (PLC) using the Pathological Laughter and Crying Scale (PLAC) in 92 consecutive patients with acute symptoms 3, 6, and 12 months after traumatic brain injury (TBI). The prevalence of PLC during the first year after TBI was 10.9%. Compared to patients without PLC, patients with PLC had significantly more depressive, anxious, and aggressive behaviors and had poorer social functioning. Additionally, PLC was associated with the presence of anxiety disorder, and focal frontal lobe lesions, especially in the lateral aspect of the left frontal lobe. Findings revealed that prefrontal regulation of limbic circuits may be involved in the pathophysiology of this disturbed emotional expression.

Entities:  

Mesh:

Year:  2004        PMID: 15616168     DOI: 10.1176/jnp.16.4.426

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  16 in total

1.  Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers.

Authors:  Kerri A Schoedel; Laura E Pope; Edward M Sellers
Journal:  Clin Drug Investig       Date:  2012-03-01       Impact factor: 2.859

Review 2.  Pathological laughing and crying : epidemiology, pathophysiology and treatment.

Authors:  Hal S Wortzel; Timothy J Oster; C Alan Anderson; David B Arciniegas
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

3.  Mean diffusivity in the amygdala correlates with anxiety in pediatric TBI.

Authors:  Jenifer Juranek; Chad P Johnson; Mary R Prasad; Larry A Kramer; Ann Saunders; Pauline A Filipek; Paul R Swank; Charles S Cox; Linda Ewing-Cobbs
Journal:  Brain Imaging Behav       Date:  2012-03       Impact factor: 3.978

4.  The Neuropsychiatric Approach to the Assessment of Patients in Neurology.

Authors:  Nicholas T Trapp; Michael R Martyna; Shan H Siddiqi; Sepideh N Bajestan
Journal:  Semin Neurol       Date:  2022-04-27       Impact factor: 3.212

Review 5.  Psychiatric disturbances after traumatic brain injury: neurobehavioral and personality changes.

Authors:  Erin M Warriner; Diana Velikonja
Journal:  Curr Psychiatry Rep       Date:  2006-02       Impact factor: 5.285

6.  Pharmacotherapy for the Pseudobulbar Affect in Individuals Who Have Sustained a Traumatic Brain Injury: a Systematic Review.

Authors:  Amelia J Hicks; Fiona J Clay; Jennie L Ponsford; Luke A Perry; Mahesh Jayaram; Rachel Batty; Malcolm Hopwood
Journal:  Neuropsychol Rev       Date:  2020-01-15       Impact factor: 7.444

7.  Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment.

Authors:  David B Arciniegas; C Alan Anderson; Jeannie Topkoff; Thomas W McAllister
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570

8.  A study of potential pharmacokinetic and pharmacodynamic interactions between dextromethorphan/quinidine and memantine in healthy volunteers.

Authors:  Laura E Pope; Kerri A Schoedel; Cynthia Bartlett; Edward M Sellers
Journal:  Clin Drug Investig       Date:  2012-08-01       Impact factor: 2.859

9.  PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions.

Authors:  Benjamin Rix Brooks; David Crumpacker; Jonathan Fellus; Daniel Kantor; Randall E Kaye
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

Review 10.  Pseudobulbar affect: prevalence and management.

Authors:  Aiesha Ahmed; Zachary Simmons
Journal:  Ther Clin Risk Manag       Date:  2013-11-29       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.